β-cell function during insulin-modified intravenous glucose tolerance test successfully assessed by the C-peptide minimal model

This publication has 10 references indexed in Scilit:

• Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.
  Journal of Clinical Investigation, 1997
• Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity
  Metabolism, 1997
• Epinephrine exerts opposite effects on peripheral glucose disposal and glucose-stimulated insulin secretion. A stable label intravenous glucose tolerance test minimal model study
  Diabetes, 1996
• Resistance exercise and growth hormone administration in older men: Effects on insulin sensitivity and secretion during a stable-label intravenous glucose tolerance test
  Metabolism, 1996
• A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study
  Diabetes, 1994
• Minimal Model Analysis of Intravenous Glucose Tolerance Test-Derived Insulin Sensitivity in Diabetic Subjects*
  Journal of Clinical Endocrinology & Metabolism, 1990
• A Modified Protocol for Estimation of Insulin Sensitivity with the Minimal Model of Glucose Kinetics in Patients with Insulin-Dependent Diabetes*
  Journal of Clinical Endocrinology & Metabolism, 1990
• Prehepaticβ-Cell Secretion During the Intravenous Glucose Tolerance Test in Humans: Application of a Combined Model of Insulin and C-Peptide Kinetics*
  Journal of Clinical Endocrinology & Metabolism, 1989
• Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics
  Diabetes, 1987
• Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.
  Journal of Clinical Investigation, 1985